These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29424288)

  • 61. Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes.
    Levy ML; Carroll W; Izquierdo Alonso JL; Keller C; Lavorini F; Lehtimäki L
    Adv Ther; 2019 Oct; 36(10):2547-2557. PubMed ID: 31478131
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial.
    Gregoriano C; Dieterle T; Breitenstein AL; Dürr S; Baum A; Maier S; Arnet I; Hersberger KE; Leuppi JD
    Respir Res; 2018 Dec; 19(1):237. PubMed ID: 30509268
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.
    Serra-Batlles J; Plaza V; Badiola C; Morejón E;
    J Aerosol Med; 2002; 15(1):59-64. PubMed ID: 12006146
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Performance Characteristics of Breezhaler
    Molimard M; Kottakis I; Jauernig J; Lederhilger S; Nikolaev I
    Clin Drug Investig; 2021 May; 41(5):415-424. PubMed ID: 33768480
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Shared Decision-Making Facilitates Inhaler Choice in Patients with Newly-Diagnosed Chronic Obstructive Pulmonary Disease: A Multicenter Prospective Study.
    Hsiao YH; Tseng CM; Sheu CC; Wang HY; Ko HK; Su KC; Tao CW; Tsai MJ; Chen YF
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2067-2078. PubMed ID: 36081765
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Genuair® inhaler: a novel, multidose dry powder inhaler.
    Chrystyn H; Niederlaender C
    Int J Clin Pract; 2012 Mar; 66(3):309-17. PubMed ID: 22340451
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate.
    Mehta R; Moore A; Riddell K; Joshi S; Chan R
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):332-338. PubMed ID: 28463040
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An Acoustic-Based Method to Detect and Quantify the Effect of Exhalation into a Dry Powder Inhaler.
    Holmes MS; Seheult JN; O'Connell P; D'Arcy S; Ehrhardt C; Healy AM; Costello RW; Reilly RB
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):247-53. PubMed ID: 25393346
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Evaluation of inhaler techniques in patients with asthma and chronic obstructive disease].
    Loukil M; Mejri I; Khalfallah I; Ghrairi H
    Rev Pneumol Clin; 2018 Sep; 74(4):226-234. PubMed ID: 30031594
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A randomised cross-over trial investigating the ease of use and preference of two dry powder inhalers in patients with asthma or chronic obstructive pulmonary disease.
    van der Palen J; van der Valk P; Goosens M; Groothuis-Oudshoorn K; Brusse-Keizer M
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1171-8. PubMed ID: 23815552
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
    Aggarwal B; Gogtay J
    Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Medication Tracking: Design and Fabrication of a Dry Powder Inhaler with Integrated Acoustic Element by 3D Printing.
    Li Y; Bohr A; Jensen H; Rantanen J; Cornett C; Beck-Broichsitter M; Bøtker JP
    Pharm Res; 2020 Jan; 37(3):38. PubMed ID: 31965333
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Ambulatory criteria of dry powder inhaler selection based on peak inspiratory flow recordings].
    Droszcz W; Droscez P
    Pneumonol Alergol Pol; 2002; 70(9-10):490-5. PubMed ID: 12710102
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Carbon footprint impact of the choice of inhalers for asthma and COPD.
    Janson C; Henderson R; Löfdahl M; Hedberg M; Sharma R; Wilkinson AJK
    Thorax; 2020 Jan; 75(1):82-84. PubMed ID: 31699805
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Optimising inhaler technique in chronic obstructive pulmonary disease: a complex issue.
    Riley J; Krüger P
    Br J Nurs; 2017 Apr; 26(7):391-397. PubMed ID: 28410043
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [New dry powder inhalers].
    Emeryk A; Pirożyński M
    Pneumonol Alergol Pol; 2015; 83(1):83-7. PubMed ID: 25577539
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genuair
    Magnussen H; Fyrnys B; Greguletz R
    COPD; 2019 Apr; 16(2):196-205. PubMed ID: 31264482
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?
    Dahl R; Kaplan A
    BMC Pulm Med; 2016 Oct; 16(1):135. PubMed ID: 27724909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.